D4476
SIGMA/D1944 - ≥98% (HPLC), solid
Synonym: 4-
CAS Number: 301836-43-1
Empirical Formula (Hill Notation): C23H18N4O3
Molecular Weight: 398.41
MDL Number: MFCD28391149
Linear Formula: C23H18N4O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | light yellow |
| form | solid |
| InChI | 1S/C23H18N4O3/c24-22(28)1 |
| InChI key | DPDZHVCKYBCJHW-UHFFFAOYSA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | NC(=O)c1ccc(cc1)-c2nc(-c3 |
| solubility | DMSO: ~20 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Application: | D4476 has been used as a casein kinase I inhibitor (CKI) in various experiments. |
| Biochem/physiol Actions: | D4476 is a potent, selective ATP-competitive inhibitor of CK1 (casein kinase 1). |
| Biochem/physiol Actions: | D4476 may prevent or enhance apoptosis. It triggers tumor suppressor p53 and impairs transcription factor E2F-1. |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

